# Efficacy and Safety Oral Contraceptive Study

> **NCT00185484** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 1113 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)

## Key facts

- **NCT ID:** NCT00185484
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 1113 (ACTUAL)
- **Last updated:** 2014-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185484, "Efficacy and Safety Oral Contraceptive Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00185484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*